Thrombosis Research Institute, London (United Kingdom of Great Britain & Northern Ireland)
13
presentations
0
follower
4
more
presentations
in this session
Introduction and welcome: evidence and guideline-based validation for factor Xa-based management of thrombosis-related disorders in cardiovascular medicine.
Practical dimensions and optimal deployment of oral factor Xa inhibitors in patients with non-valvular atrial fibrillation: the role of key clinical factors.
Interactive case-based simulation focused on stroke prevention in atrial fibrillation: practical, real world management decisions using oral factor Xa inhibitors in patients with non-valvular atrial fibrillation.
Summary and take home messages: the foundation role of oral factor Xa inhibition for stroke prevention in atrial fibrillation and acute and extended management of venous thromboembolism.